Can I read Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology on EtoBox?

Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology by José Baddini-Martinez; Juliana Ferreira; Suzana Tanni; Luis Renato Alves; Benedito Francisco Cabral Junior; Carlos Roberto Ribeiro Carvalho; Talita Jacon Cezare; Claudia Henrique da Costa; Marcelo Basso Gazzana; Sérgio Jezler; Ronaldo Adib Kairalla; Leticia Kawano-Dourado; Mariana Silva Lima; Eliane Mancuzo; Maria Auxiliadora Carmo Moreira; Marcelo Palmeira Rodrigues; Silvia Carla Sousa Rodrigues; Adalberto Sperb Rubin; Rogério Lopes Rufino; Leila John Marques Steidle; Karin Storrer; Bruno Guedes Baldi is a Medicine article available to read on EtoBox.

What is Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology about?

## ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a form of chronic interstitial lung disease of unknown cause, which predominantly affects elderly men who are current or former smokers. Even though it is an uncommon disease, it is of great importance because of its severity and poor prognosis. In recent decades, several pharmacological treatment modalities have been investigated for the treatment of this disease, and the classic concepts have therefore been revised. The purpose of these guidelines was to define evidence-based recommendations regarding the use of pharmacological agents in the treatment of IPF in Brazil. We sought to provide guidance on the practical issues faced by clinicians in their daily lives. Patients of interest, Intervention to be studied, Comparison of intervention and Outcome of interest (PICO)-style questions were formulated to address aspects related to the use of corticosteroids, N-acetylcysteine, gastroesophageal reflux medications, endothelin-receptor antagonists, phosphodiesterase-5 inhibitors, pirfenidone, and nintedanib. To formulate the PICO questions, a group of Brazilian specialists working in the area was assembled and an extensive review of t

Who reads Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology?

Author

José Baddini-Martinez; Juliana Ferreira; Suzana Tanni; Luis Renato Alves; Benedito Francisco Cabral Junior; Carlos Roberto Ribeiro Carvalho; Talita Jacon Cezare; Claudia Henrique da Costa; Marcelo Basso Gazzana; Sérgio Jezler; Ronaldo Adib Kairalla; Leticia Kawano-Dourado; Mariana Silva Lima; Eliane Mancuzo; Maria Auxiliadora Carmo Moreira; Marcelo Palmeira Rodrigues; Silvia Carla Sousa Rodrigues; Adalberto Sperb Rubin; Rogério Lopes Rufino; Leila John Marques Steidle; Karin Storrer; Bruno Guedes Baldi

Published

2020

Language

EN

Field

Medicine (Health Sciences)